← All trials
NCT06215144
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 25, 2024
- Primary completion
- Dec 30, 2024
- Completion date
- Feb 1, 2025
- First posted
- Jan 22, 2024
- Last posted
- Mar 20, 2024
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Neurocentria, Inc.Lead sponsor
- Neurocentria, Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.